It revealed a total of 549 pathways for colchicine in the treatment of CAD, which involved cellular response to chemical stress, p75NTR-mediated SC1 negative regulation of cell cycle, transcriptional activation of mitochondrial biogenesis, Notch-HLH transcriptional pathway and FOXO-mediated transcription. Here, NGFR is linked to coronary artery disorder.